Skip to content

Fecal Microbiota Transplantation in Patients with Ulcerative Colitis

Feasibility Study of Fecal Microbiota Transplantation (FMT) in Patients with Ulcerative Colitis

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210113050024N1
Enrollment
5
Registered
2021-02-08
Start date
2021-04-08
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis. Ulcerative colitis

Interventions

Intervention group: 5 patients with ulcerative colitis and 5 healthy donors according to inclusion and exclusion criteria using non-probable method will enter into the study. The fresh stool samples w

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: For the patients: the volunteers aged 18-65 years with Ulcerative Colitis who have been diagnosed by 3 months and are in moderate-severe phase For the stool donor: the healthy volunteers aged 18-65 years

Exclusion criteria

Exclusion criteria: For the stool donor: Having signs or existence of gastro- enteric diseases existence of other diseases like diabetes, cardiovascular, liver, and kidney diseases Using antibiotic/ anti fungal/ anti viral or probiotics Using immunosuppressive and anti carcinogenic drugs affected by autoimmune and atopic diseases With metabolic syndrome, obesity(BMI>30) or under nutrition(BMI<18) chronic pain syndrome, psychological diseases, and carcinoma Infectious disease like hepatitis B, hepatitis C, AIDS, and respiratory infections Close contact to somebody who have had viral hepatitis or AIDS during the last year high risk behaviors like sigh risky sex, tattooing, or piercing in the last 6 months consumption illegal drugs and opium going to diarrheic endemic zone during the last 6 months the history of inflammation bowel diseases, chronic diarrhea and the other GI diseases the history of GI cancer or Polyposis the history of colorectal cancer in the first degree relatives the history of GI surgery like bypass infected by corona virus

Design outcomes

Primary

MeasureTime frame
The clinical score based on Lightiger test. Timepoint: at the first(mo 0), after intervention period(mo 2), at the end(mo 4). Method of measurement: using Lightiger questionnaire.;Quantity of intestinal targeted bacteria. Timepoint: at the first(mo 0), and at the end(mo 4) of study. Method of measurement: Q-PCR.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNazila Kassaian

Esfahan University of Medical Sciences

nkassaian@gmail.com+98 31 3237 4705

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026